Testosterone deficiency: a risk factor for cardiovascular disease?

Area of Science:

• Endocrinology
• Cardiology
• Metabolic Health

Background:

• Male gender is a significant risk factor for premature cardiovascular death.
• Low testosterone (hypogonadism) is associated with metabolic syndrome, type 2 diabetes, and cardiovascular risk factors.
• Epidemiological studies indicate higher mortality rates in men with low testosterone levels.

Purpose of the Study:

• To review the current evidence linking low testosterone to cardiovascular disease in men.
• To highlight the potential benefits of testosterone replacement therapy on cardiovascular health.
• To underscore the need for further research in this area.

Main Methods:

• Review of epidemiological studies and clinical trials.
• Analysis of the association between testosterone levels and cardiovascular outcomes.
• Evaluation of the effects of testosterone replacement therapy.

Main Results:

• Low testosterone is independently associated with metabolic syndrome components: visceral obesity, insulin resistance, hyperglycemia, hypertension, and dyslipidemia.
• Short-term testosterone replacement improved waist circumference, lipid profiles, inflammatory markers, insulin sensitivity, and glycemic control.
• Testosterone therapy demonstrated positive effects on cardiac ischemia, angina, and chronic heart failure.

Conclusions:

• A significant link exists between low testosterone and increased cardiovascular disease risk and mortality in men.
• Testosterone replacement therapy may offer therapeutic benefits for cardiovascular health and metabolic dysfunction.
• Larger, long-term studies are required to confirm these findings and establish clinical guidelines.